New facility will enable end‑to‑end discovery across key disease areas and technology platforms, joining existing global research sites including Cambridge,…
AlUla, Saudi Arabia, Feb. 7, 2026 /PRNewswire/ -- The second edition of the AlUla Conference for Emerging Market Economies 2026…
Late-breaking Phase III FENtrepid results presented at ACTRIMS show investigational fenebrutinib met its primary endpoint of non-inferiority compared to the…
February 06, 2026 17:17 ET | Source: Lexicon Pharmaceuticals, Inc. THE WOODLANDS, Texas, Feb. 06, 2026 (GLOBE NEWSWIRE) -- Lexicon…
New York, NY, Feb. 06, 2026 (GLOBE NEWSWIRE) -- Disclaimer: This article is for informational purposes only. It is not…
Breakthrough Phase 2 Trial Results Show Promise for Patients Ineligible for Standard Reperfusion TherapiesData Presented at International Stroke ConferenceData Show…
KUALA LUMPUR, Malaysia, Feb. 6, 2026 /PRNewswire/ -- EVE Energy Co., Ltd. and its partners signed a contract for the…
NEW YORK, Feb. 06, 2026 (GLOBE NEWSWIRE) -- There were 956 commercial Chapter 11 filings in January 2026, an increase…
Initial Determination Decision Protects Validity of Shoals Intellectual Property February 06, 2026 16:24 ET | Source: Shoals Technologies Group PORTLAND,…
February 06, 2026 16:10 ET | Source: Veeco Instruments Inc. PLAINVIEW, N.Y., Feb. 06, 2026 (GLOBE NEWSWIRE) -- Veeco Instruments…